Cargando…
Corrigendum: Tumour‐associated macrophages as a novel target of VEGI‐251 in cancer therapy
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980914/ https://www.ncbi.nlm.nih.gov/pubmed/35384287 http://dx.doi.org/10.1111/jcmm.17271 |
Ejemplares similares
-
Tumour‐associated macrophages as a novel target of VEGI‐251 in cancer therapy
por: Dong, Xinhuai, et al.
Publicado: (2020) -
Corrigendum to “Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents” [J Hosp Infect 104 (2020) 246–251]
por: Kampf, G., et al.
Publicado: (2020) -
Corrigendum to: “Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis” [J Hepatol (2020) 241-251]
por: Parisinos, Constantinos A., et al.
Publicado: (2020) -
[Corrigendum] Neuroprotective effect of emodin against Alzheimer’s disease via Nrf2 signaling in U251 cells and APP/PS1 mice
por: Li, Zhiping, et al.
Publicado: (2023) -
Preparation and Characterization of a Novel Chimeric Protein VEGI-CTT in Escherichia coli
por: Cai, Jiping, et al.
Publicado: (2008)